Page last updated: 2024-11-08

diethylnitrosamine and Dyslipidemia

diethylnitrosamine has been researched along with Dyslipidemia in 1 studies

Diethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.
N-nitrosodiethylamine : A nitrosamine that is N-ethylethanamine substituted by a nitroso group at the N-atom.

Research Excerpts

ExcerptRelevanceReference
"Pitavastatin is effective in inhibiting the early phase of obesity-related liver tumorigenesis and, therefore, may be useful in the chemoprevention of liver cancer in obese individuals."3.77Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/db obese mice. ( Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Sakai, H; Shimizu, M; Tanaka, T; Terakura, D; Tsurumi, H; Yasuda, Y, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimizu, M1
Yasuda, Y1
Sakai, H1
Kubota, M1
Terakura, D1
Baba, A1
Ohno, T1
Kochi, T1
Tsurumi, H1
Tanaka, T1
Moriwaki, H1

Other Studies

1 other study available for diethylnitrosamine and Dyslipidemia

ArticleYear
Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/db obese mice.
    BMC cancer, 2011, Jun-28, Volume: 11

    Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Apoptosis; bcl-Associated Death Protein; Cocarc

2011